Grail, Epic Expand Cancer Test Integration

Grail and Epic are expanding their partnership to integrate Grail's Galleri cancer test across 450 health systems. This collaboration aims to increase patient access to the multi-cancer early detection test. Despite the trial missing its primary endpoint, it showed a trend towards reducing Stage IV cancer diagnoses. The expanded integration with Epic's electronic health record system is expected to facilitate wider adoption and further clinical evaluation of the Galleri test.